Financial Express (Holdings) Limited (“we”, “our”, “us” and derivatives) are committed to protecting and respecting your privacy. This Privacy Policy, together with our Terms of Use, sets out the basis on which any personal data that we collect from you, or that you provide to us, will be processed by us relating to your use of any of the below websites (“sites”).


For the purposes of the Data Protection Act 1998, the data controller is Trustnet Limited of 2nd Floor, Golden House, 30 Great Pulteney Street, London, W1F 9NN. Our nominated representative for the purpose of this Act is Kirsty Witter.


We collect information about you when you register with us or use any of our websites / services. Part of the registration process may include entering personal details & details of your investments.

We may collect information about your computer, including where available your operating system, browser version, domain name and IP address and details of the website that you came from, in order to improve this site.

You confirm that all information you supply is accurate.


In order to provide personalised services to and analyse site traffic, we may use a cookie file which is stored on your browser or the hard drive of your computer. Some of the cookies we use are essential for the sites to operate and may be used to deliver you different content, depending on the type of investor you are.

You can block cookies by activating the setting on your browser which allows you to refuse the setting of all or some cookies. However, if you use your browser settings to block all cookies (including essential cookies) you may not be able to access all or part of our sites. Unless you have adjusted your browser setting so that it will refuse cookies, our system will issue cookies as soon as you visit our sites.


We store and use information you provide as follows:

  • to present content effectively;
  • to provide you with information, products or services that you request from us or which may interest you, tailored to your specific interests, where you have consented to be contacted for such purposes;
  • to carry out our obligations arising from any contracts between you and us;
  • to enable you to participate in interactive features of our service, when you choose to do so;
  • to notify you about changes to our service;
  • to improve our content by tracking group information that describes the habits, usage, patterns and demographics of our customers.

We may also send you emails to provide information and keep you up to date with developments on our sites. It is our policy to have instructions on how to unsubscribe so that you will not receive any future e-mails. You can change your e-mail address at any time.

In order to provide support on the usage of our tools, our support team need access to all information provided in relation to the tool.

We will not disclose your name, email address or postal address or any data that could identify you to any third party without first receiving your permission.

However, you agree that we may disclose to any regulatory authority to which we are subject and to any investment exchange on which we may deal or to its related clearing house (or to investigators, inspectors or agents appointed by them), or to any person empowered to require such information by or under any legal enactment, any information they may request or require relating to you, or if relevant, any of your clients.

You agree that we may pass on information obtained under Money Laundering legislation as we consider necessary to comply with reporting requirements under such legislation.


We want to ensure that the personal information we hold about you is accurate and up to date. You may ask us to correct or remove information that is inaccurate.

You have the right under data protection legislation to access information held about you. If you wish to receive a copy of any personal information we hold, please write to us at 3rd Floor, Hollywood House, Church Street East, Woking, GU21 6HJ. Any access request may be subject to a fee of £10 to meet our costs in providing you with details of the information we hold about you.


The data that we collect from you may be transferred to, and stored at, a destination outside the European Economic Area (“EEA”). It may be processed by staff operating outside the EEA who work for us or for one of our suppliers. Such staff may be engaged in, amongst other things, the provision of support services. By submitting your personal data, you agree to this transfer, storing and processing. We will take all steps reasonably necessary, including the use of encryption, to ensure that your data is treated securely and in accordance with this privacy policy.

Unfortunately, the transmission of information via the internet is not completely secure. Although we will do our best to protect your personal data, we cannot guarantee the security of your data transmitted to our sites; any transmission is at your own risk. You will not hold us responsible for any breach of security unless we have been negligent or in wilful default.


Any changes we make to our privacy policy in the future will be posted on this page and, where appropriate, notified to you by e-mail.


Our sites contain links to other websites. If you follow a link to any of these websites, please note that these websites have their own privacy policies and that we do not accept any responsibility or liability for these policies. Please check these policies before you submit any personal data to these websites.


If you want more information or have any questions or comments relating to our privacy policy please email in the first instance.

 Information  X 
Enter a valid email address

Virotec Intl. PLC (VTI)

  Print      Mail a friend

Friday 27 April, 2007

Virotec Intl. PLC

Issue of Equity

Virotec International PLC
27 April 2007

                           VIROTEC INTERNATIONAL PLC
26 April 2007

                              ISSUES OF SECURITIES

Virotec International plc ('Virotec') (AIM:VTI) advises that it has issued the
following securities:

6,655,789  Ordinary shares of 1p each issued at a price of £0.14 per share to 
           the incentive plans for executives as approved by shareholders at 
           the Annual General Meeting on 28 November 2003.

7,000,000  Options exercisable at a price of £0.20 each vesting over 5 years 
           between April 2007 and April 2011 subject to the achievement of
           performance criteria and expiring 3 years after vesting, to the 
           recently appointed CEO, Dr Lee Fergusson, which forms part of his 
           remuneration package for his new position.

3,400,000  Options exercisable at a price of £0.20 each on or before 30 April 
           2012 issued to directors and employees pursuant to the Virotec Option
           Incentive Scheme.

Application will be been made for the 6,655,789 New Ordinary Shares of 1p each
to be admitted to trading on the AIM market of the London Stock Exchange. The
New Ordinary Shares will rank pari passu with existing ordinary shares and it is
expected that admission will become effective at 8.00 a.m. on Tuesday 1 May 

All of the options noted above were issued to employees pursuant to the Virotec
Option Incentive Scheme (the 'Scheme'). Under the terms of the Scheme, options
can generally only be exercised by employees during two periods each year, being
one month immediately following the release of the half year and one month
immediately following the release of the full year financial results.

The following options have lapsed or have been cancelled:

5,000,000  Options exercisable at a price of £0.40 each at various times
           between 1 July 2006 and 30 September 2015 to senior executives.
150,000    Options exercisable at £0.20 each on or before 30 September 2006.
10,000     Options exercisable at £0.20 each on or before 31 March 2007.
110,000    Options exercisable at £0.20 each on or before 30 September 2007.
110,000    Options exercisable at £0.28 each on or before 31 March 2009.

Following successful completion of the placing announced on 28 March 2007 of
17,350,000 ordinary shares, the current issued capital of Virotec following the
issue of the securities referred to above comprises: 

  264,168,231  Ordinary shares of 1p each;  and 
  16,480,000   Options with various expiry dates between 30 September 2007 and 
               30 April 2014 and exercisable at prices between £0.20 and £0.40 

Angus Craig
Company Secretary

                           VIROTEC INTERNATIONAL PLC
                                   PO BOX 188
                            SANCTUARY COVE QLD 4212

                      This information is provided by RNS
            The company news service from the London Stock Exchange

a d v e r t i s e m e n t